Latest Insider Transactions at Health Sciences Acquisitions Corp 2 (HSAQ)
This section provides a real-time view of insider transactions for Health Sciences Acquisitions Corp 2 (HSAQ). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Health Sciences Acquisitions Corp 2 to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Health Sciences Acquisitions Corp 2's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 25
2024
|
David P Hochman Director |
BUY
Open market or private purchase
|
Indirect |
1,000
+0.3%
|
$6,000
$6.95 P/Share
|
|
Jun 20
2024
|
David Pacitti Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,376
+23.45%
|
-
|
|
Jun 20
2024
|
Eric S Fain Director |
BUY
Grant, award, or other acquisition
|
Indirect |
5,376
+10.3%
|
-
|
|
Jun 20
2024
|
Eric A Md Rose Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,376
+41.61%
|
-
|
|
Jun 20
2024
|
Jason Aryeh Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,376
+7.29%
|
-
|
|
Jun 20
2024
|
Connealy Pamela Yanchik Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,376
+20.16%
|
-
|
|
May 30
2024
|
William Reed Little Officer |
BUY
Open market or private purchase
|
Direct |
4,000
+1.28%
|
$28,000
$7.0 P/Share
|
|
May 17
2024
|
David P Hochman Director |
BUY
Grant, award, or other acquisition
|
Indirect |
3,000
+0.89%
|
$15,000
$5.15 P/Share
|
|
May 16
2024
|
David P Hochman Director |
BUY
Grant, award, or other acquisition
|
Indirect |
2,000
+0.6%
|
$8,000
$4.75 P/Share
|
|
May 08
2024
|
Yuval Mika Officer |
BUY
Grant, award, or other acquisition
|
Direct |
69,333
+30.38%
|
-
|
|
May 08
2024
|
Darren Sherman Director |
BUY
Grant, award, or other acquisition
|
Direct |
176,667
+18.09%
|
-
|
|
May 08
2024
|
David P Hochman Director |
BUY
Grant, award, or other acquisition
|
Indirect |
100,000
+23.39%
|
-
|
|
May 08
2024
|
David P Hochman Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+15.03%
|
-
|
|
May 08
2024
|
George Papandreou Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,000
+34.38%
|
-
|
|
May 08
2024
|
Andrew Lawrence Taylor Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+20.9%
|
-
|
|
May 08
2024
|
William Reed Little Officer |
BUY
Grant, award, or other acquisition
|
Direct |
53,333
+14.93%
|
-
|
|
Mar 26
2024
|
David Pacitti Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+45.11%
|
-
|
|
Jul 20
2023
|
Geoffrey Wade Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,667
+44.35%
|
-
|
|
Jul 20
2023
|
Joshua Aiello Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|
|
Jul 20
2023
|
Yuval Mika Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+30.87%
|
-
|
|
Jul 20
2023
|
Connealy Pamela Yanchik Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,667
+42.3%
|
-
|
|
Jul 20
2023
|
William Reed Little Officer |
BUY
Grant, award, or other acquisition
|
Direct |
250,526
+50.0%
|
-
|
|
Jul 20
2023
|
Andrew Lawrence Taylor Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
278,363
+50.0%
|
-
|
|
Jul 20
2023
|
Darren Sherman Director |
BUY
Grant, award, or other acquisition
|
Direct |
539,667
+46.4%
|
-
|
|
Jul 20
2023
|
David P Hochman Director |
BUY
Grant, award, or other acquisition
|
Indirect |
165,000
+42.04%
|
-
|
|
Jul 20
2023
|
David P Hochman Director |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+39.19%
|
-
|
|
Jul 20
2023
|
Eric S Fain Director |
BUY
Grant, award, or other acquisition
|
Indirect |
11,667
+21.97%
|
-
|
|
May 17
2023
|
Eric A Md Rose Director |
SELL
Payment of exercise price or tax liability
|
Direct |
157
-6.75%
|
$2,512
$16.04 P/Share
|
|
May 17
2023
|
Eric A Md Rose Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,325
+50.0%
|
$2,325
$1.08 P/Share
|
|
May 10
2023
|
Eric S Fain Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
2,906
+8.89%
|
$2,906
$1.08 P/Share
|
|
Apr 13
2023
|
Rtw Investments, LP > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
502,133
+8.2%
|
-
|
|
Apr 12
2023
|
Geoffrey Wade Smith Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
327,617
+15.15%
|
-
|
|
Apr 12
2023
|
Geoffrey Wade Smith Director |
BUY
Exercise of conversion of derivative security
|
Direct |
758
+15.15%
|
-
|
|
Apr 12
2023
|
Yuval Mika Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,852
+15.15%
|
-
|
|
Apr 12
2023
|
Jason Aryeh Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,246
+15.15%
|
-
|
|
Apr 12
2023
|
Michael Kaswan Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
29,029
+15.15%
|
-
|
|
Apr 12
2023
|
Connealy Pamela Yanchik Director |
BUY
Exercise of conversion of derivative security
|
Direct |
758
+15.15%
|
-
|
|
Apr 12
2023
|
Eric S Fain Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
4,796
+15.15%
|
-
|
|
Apr 12
2023
|
Darren Sherman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
14,959
+15.15%
|
-
|
|
Apr 12
2023
|
David P Hochman Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
11,843
+15.15%
|
-
|
|
Apr 12
2023
|
David P Hochman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
29,551
+15.15%
|
-
|
|
Jan 30
2023
|
Medtronic PLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
6,835
+0.14%
|
$61,515
$9.28 P/Share
|
|
Jan 26
2023
|
Michael Kaswan Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
133,545
+50.0%
|
-
|
|
Jan 26
2023
|
Yuval Mika Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,720
+50.0%
|
-
|
|
Jan 26
2023
|
Jason Aryeh Director |
BUY
Grant, award, or other acquisition
|
Direct |
51,738
+50.0%
|
-
|
|
Jan 26
2023
|
Connealy Pamela Yanchik Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,488
+50.0%
|
-
|
|
Jan 26
2023
|
Darren Sherman Director |
BUY
Grant, award, or other acquisition
|
Direct |
68,189
+50.0%
|
-
|
|
Jan 26
2023
|
David P Hochman Director |
BUY
Grant, award, or other acquisition
|
Indirect |
54,482
+50.0%
|
-
|
|
Jan 26
2023
|
David P Hochman Director |
BUY
Grant, award, or other acquisition
|
Direct |
135,947
+50.0%
|
-
|
|
Jan 26
2023
|
Eric S Fain Director |
BUY
Grant, award, or other acquisition
|
Indirect |
22,065
+50.0%
|
-
|